# Asociación Española de Gastroenterologia (Spanish Gastroenterology Association) Gastroesophageal Reflux Disease Guideline - Prospective Study

> **NCT00697008** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 300 (estimated)

## Conditions studied

- GERD

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00697008
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2009-01
- **Final completion:** —
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2009-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00697008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00697008, "Asociación Española de Gastroenterologia (Spanish Gastroenterology Association) Gastroesophageal Reflux Disease Guideline - Prospective Study". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00697008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*